Common arthritis drugs linked to bone breaks? new study investigates

NCT ID NCT06812481

Recruiting now Knowledge-focused Sponsor: Balikesir University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study looks at whether drugs with anticholinergic effects increase the risk of bone fractures in people with rheumatoid arthritis. Researchers will track 100 patients, measuring their medication burden and bone density. The goal is to better understand how these commonly used drugs might affect bone health.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help doctors identify which rheumatoid arthritis patients are at higher risk of fractures due to their medications, leading to safer prescribing.
What could go wrong: This is a small, observational study with only 100 participants, so results may not apply to everyone. It measures risk but does not test a new treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANTICHOLINERGIC ADVERSE REACTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bone fracture rheumatoid arthritis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANTICHOLINERGIC ADVERSE REACTION FRACTURES, BONE RHEUMATOID ARTHRITIS (RA)

Contacts and locations

Locations

Balikesir University Health Practice and Research Hospital
RECRUITING

Balıkesir, 10145, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.